BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38268163)

  • 21. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.
    Ghoshal K; Motiwala T; Claus R; Yan P; Kutay H; Datta J; Majumder S; Bai S; Majumder A; Huang T; Plass C; Jacob ST
    PLoS One; 2010 Apr; 5(4):e10338. PubMed ID: 20454457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
    Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
    Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis.
    Pan X; Ji P; Deng X; Chen L; Wang W; Li Z
    Gene; 2022 Feb; 810():146054. PubMed ID: 34737001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
    Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
    Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.
    Götze S; Feldhaus V; Traska T; Wolter M; Reifenberger G; Tannapfel A; Kuhnen C; Martin D; Müller O; Sievers S
    BMC Cancer; 2009 Dec; 9():447. PubMed ID: 20017917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique patterns of CpG island methylation in inflammatory bowel disease-associated colorectal cancers.
    Olaru AV; Cheng Y; Agarwal R; Yang J; David S; Abraham JM; Yu W; Kwon JH; Lazarev M; Brant SR; Marohn MR; Hutcheon DF; Harpaz N; Meltzer SJ; Mori Y
    Inflamm Bowel Dis; 2012 Apr; 18(4):641-8. PubMed ID: 21830278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation.
    Greco SA; Chia J; Inglis KJ; Cozzi SJ; Ramsnes I; Buttenshaw RL; Spring KJ; Boyle GM; Worthley DL; Leggett BA; Whitehall VL
    BMC Cancer; 2010 Sep; 10():494. PubMed ID: 20846368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island.
    Zhang Y; Shu J; Si J; Shen L; Estecio MR; Issa JP
    Nucleic Acids Res; 2012 Aug; 40(15):7257-68. PubMed ID: 22600741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
    Boot A; Oosting J; van Eendenburg JDH; Kuppen PJK; Morreau H; van Wezel T
    PLoS One; 2017; 12(9):e0184900. PubMed ID: 28931069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells.
    Javierre BM; Rodriguez-Ubreva J; Al-Shahrour F; Corominas M; Graña O; Ciudad L; Agirre X; Pisano DG; Valencia A; Roman-Gomez J; Calasanz MJ; Prosper F; Esteller M; Gonzalez-Sarmiento R; Ballestar E
    Mol Cancer Res; 2011 Aug; 9(8):1139-51. PubMed ID: 21737484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer.
    Trojan J; Brieger A; Raedle J; Esteller M; Zeuzem S
    Gut; 2000 Aug; 47(2):272-6. PubMed ID: 10896921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
    Luebeck EG; Curtius K; Hazelton WD; Maden S; Yu M; Thota PN; Patil DT; Chak A; Willis JE; Grady WM
    Clin Epigenetics; 2017; 9():113. PubMed ID: 29046735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation of methylation of CpG island in cystathionine beta synthase promoter and clinicopathological features in colorectal cancer].
    Tu XH; Huang SX; Li WS; Song JX
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):351-5. PubMed ID: 24054011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis.
    Balaguer F; Link A; Lozano JJ; Cuatrecasas M; Nagasaka T; Boland CR; Goel A
    Cancer Res; 2010 Aug; 70(16):6609-18. PubMed ID: 20682795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains.
    Berman BP; Weisenberger DJ; Aman JF; Hinoue T; Ramjan Z; Liu Y; Noushmehr H; Lange CP; van Dijk CM; Tollenaar RA; Van Den Berg D; Laird PW
    Nat Genet; 2011 Nov; 44(1):40-6. PubMed ID: 22120008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.
    Lujambio A; Portela A; Liz J; Melo SA; Rossi S; Spizzo R; Croce CM; Calin GA; Esteller M
    Oncogene; 2010 Dec; 29(48):6390-401. PubMed ID: 20802525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.